Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Science1976Vol. 192(4238), pp. 481–483
Citations Over TimeTop 1% of 1976 papers
Abstract
Tritiated haloperidol and tritiated dopamine label postsynaptic dopamine receptors in mammalian brain. Clinical potencies of butyrophenones, phenothiazines, and related drugs correlate closely with their ability to inhibit tritiated haloperidol binding. These binding methods provide a simple in vitro means for evaluating new drugs as potential antischizophrenic agents.
Related Papers
- → The Prospective Value of Dopamine Receptors on Bio-Behavior of Tumor(2019)82 cited
- → Dopamine and Dopamine-Related Ligands Can Bind Not Only to Dopamine Receptors(2022)16 cited
- → Dopamine antagonists induce gastric lesions in rats(1986)37 cited
- → Electrooculographic and electroretinographic study in the chicken after dopamine and haloperidol(1990)26 cited
- → ChemInform Abstract: Dopamine Receptors: Studies on Structure and Function(1996)1 cited